Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial.
Vaccines (Basel)
; 9(10)2021 Oct 19.
Article
in En
| MEDLINE
| ID: mdl-34696316
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Language:
En
Journal:
Vaccines (Basel)
Year:
2021
Document type:
Article